Gender as risk factor for autoimmune diseases

Journal of Autoimmunity

Volumn 28, Issue 1, 2007, Pages 1-6

  Gleicher, Norbert ^a,b,c   Barad, David H ^a,b,d  

^a CENTER FOR HUMAN REPRODUCTION   (United States)

^b Foundation for Reproductive Medicine   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmune diseases; Autoimmunity; Cell traffic; Cesarean section; Evolution; Gender; Gender differences; Microchimerism; Pregnancy; Sex hormones; Vaginal delivery

Indexed keywords

ESTROGEN; SEX HORMONE;

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; CELL MIGRATION; FETOMATERNAL TRANSFUSION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; MICROCHIMERISM; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; X CHROMOSOME;

AUTOIMMUNE DISEASES; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; RISK FACTORS; SEX FACTORS;

EID: 33847083891     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2006.12.004     Document Type: Article

References (55)

1. National Institutes of Health Autoimmune Disease Coordinating Committee Report, 2002, Bethesda, MD, The Institutes; 2002.
2. Gleicher N. An evolutionary concept of polycystic ovarian disease: does evolution favour reproductive success over survival?. Reprod Biomed Online 12 (2006) 587-589
3. Whitacre C.C. Sex differences in autoimmune disease. Nat Immunol 2 (2001) 777-780
4. McCarthy M. The "gender gap" in autoimmune disease. Lancet 356 (2000) 1088
5. Beageley K.W., and Gockel C.M. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 38 (2003) 13-22
6. Gleicher N. Some thoughts on the reproductive autoimmune failure syndrome (RAFS) and TH-1 versus TH-2 immune responses. Am J Reprod Immunol 48 (2002) 252-254
7. Yakoo T., Takakuwa K., Ooki I., Kikuchi A., Tamura M., and Tanaka K. Alterations of TH1 and TH2 cells by intracellular cytokine detection in patients with unexplained recurrent abortion before and after immunotherapy with the husband's mononuclear cells. Fertil Steril 85 (2006) 1452-1458
8. Cutolo M. Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 31 (2004) 419-421
9. Madkan V.K., Giancola A.A., Sra K.K., and Tyring S.K. Anatomical and hormonal influences on women's dermatologic health. Arch Dermatol 142 (2006) 365-370
10. Van Vollenhofen R.F. Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. Expert Opin Pharmacother 3 (2003) 23-31
11. Lockshin M.D. Sex ratio and rheumatic disease. IMAJ 3 (2001) 511-516
12. Klein S.L. The effect of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav 24 (2000) 627-638
13. Iaccarino D., Ghirardello A., Zampieris S., Arientis S., Sarzi-Puttini P., Atzeni F., et al. Long term prognosis and cause of death in systemic lupus erythematosus. Am J Med 119 (2006) 700-706
14. Davidson A., and Diamond B. Autoimmune diseases. N Engl J Med 345 (2001) 340-350
15. Gleicher N., Weiner R., and Vietzke M. The impact of abnormal autoimmune function on reproduction: maternal and fetal consequences. J Autoimmun 27 (2006) 161-165
16. Angier N. Studying the autoimmune disease puzzle. http://www.nytimes.com/201/06/19/health/19AUTO.html
17. Hayashi T., and Fustman D.L. Role of defective apoptosis in type 1 diabetes and other autoimmune diseases. Recent Prog Horm Res 58 (2003) 131-153
18. Invernizzi P., Miozzo M., Selmi C., Persani L., Bettezzati P.M., Zuin M., et al. Chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 175 (2005) 575-578
19. Selmi C., Invernizzi P., and Gershwin M.E. The X chromosome and systemic sclerosis. Curr Opin Rheumatol 18 (2006) 601-605
20. Stevens A.M., Tsao B.P., Hahn B.H., Guthrie K., Lambert N.C., Porter A.J., et al. Maternal HLA class II compatibility in men with systemic lupus erythematosus. Arthritis Rheum 52 (2005) 2768-2773
21. Raulet D.H. Does a low level of expression of HLA molecules engender autoimmunity?. N Engl J Med 340 (1999) 3124-3125
22. Lo Y.M., Lo E.S., Watson N., Noakes L., Sargent I.L., Thilaganathan B., et al. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 88 (1996) 4390-4395
23. Bianchi D.W., and Romero R. Biological implications of bi-directional fetomaternal cell traffic: a summary of a National Institute of Chile Health and Human Development-sponsored conference. J Matern Fetal Neonatal Med 14 (2003) 123-129
24. Read J.S., and Newell M.K. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. Cochrane Database Syst Rev 19 (2005) CD005479
25. Feldman N., Skoll A., and Sibai B. The incidence of significant fetomaternal hemorrhage in patients undergoing cesarean section. Am J Obstet Gynecol 163 (1990) 855-858
26. Starzl D.E., Demetris A.J., Murase N., Ildstad S., Ricodi C., and Trucco M. Cell migration, chimerism and graft acceptance. Lancet 339 (1992) 1579-1582
27. Quaini F., Urbanek K., Beltrami A.P., Finato N., Beltrami C.A., Nadal-Ginard B., et al. Chimerism of the transplanted heart. N Engl J Med 346 (2002) 5-15
28. Kolialexi A., Tsangaris G.T., Antsklis A., and Mavroua A. Rapid clearance of fetal cells from maternal circulation after delivery. Ann NY Acad Sci 1022 (2004) 113-118
29. Artlett C.M., O'Hanlon T.P., Lopez A.M., Song Y.W., Miller F.W., and Rider L.G. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and healthy individuals. Arthritis Rheum 48 (2003) 2567-2572
30. Tivol E., Komorowski R., and Drbyski W.R. Emergent autoimmunity in graft-versus-host disease. Blood 105 (2005) 4885-4891
31. Rose M.L. Activation of autoimmune B cells and chronic rejection. Transplantation 15 79 (2005) S22-S24
32. Gleicher N. Why much of the pathophysiology of preeclampsia/eclampsia has to be "autoimmune" in nature. Am J Obstet Gynecol 196 (2007) 5.e1-5.e7
33. Johnson K.L., and Bianchi D.W. Fetal cells in maternal tissue following pregnancy: what are the consequences?. Hum Reprod Update 10 (2004) 497-502
34. Khosrotehrani K., and Bianchi D.W. Multi lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci 118 (2005) 1559-1563
35. Lambert N.C., Erickson T.D., Yan Z., Pang J.M., Guthrie K.A., Furst B.E., et al. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritic Rheum 50 (2004) 906-914
36. Khosrotehrani K., Many L., Aractingis S., Bianchi D.W., and Johnson K.L. Absence of fetal cell microchimerism is cutaneous lesions of lupus erythematosus. Ann Rheum Dis 64 (2005) 159-160
37. Nelson J.L. Microchimerism in human health and disease. Autoimmunity 36 (2003) 5-9
38. Gleicher N., Pratt A., and Dudkiewicz A. What do we really know about antibody abnormalities and reproductive failure: a critical review. Autoimmunity 16 (1993) 115-140
39. Gilliam A.C. Microchimerism and skin disease: true-true unrelated?. J Invest Dermatol 126 (2006) 239-241
40. Ivakine E.A., Fox C.J., Paterson A.D., Morton-Toth S., Canty A., Walton D.S., et al. Sex-specific effect of insulin-dependent diabetes IV on regulation of diabetes pathogenesis in the nonobese diabetic mouse. J Immune 174 (2005) 7129-7140
41. Ozbalkan Z., Bagislar S., Kiraz S., Akyerli C.B., Ozer H.T., Yavuz S., et al. Skewed X-chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 52 (2005) 1564-1570
42. Ozcelik T., Uz E., Akyerli C.B., Bagislar S., Mustafa C.A., Gursoy A., et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet 14 (2006) 791-797
43. Sibai D., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-789
44. Walsh J.P., Bremner A.P., Bulsara M.K., O'Leary P., Leedman P.J., Feddema P., et al. Parity and the risk of autoimmune thyroid disease: a community-based study. J Clin Endocrinol Metab 90 (2005) 5309-5312
45. Basso O., Campi R., Frydenberg M., Koch-Henriksen N., Bronnum-Hansen H., and Olsen J. Mult Scler 10 (2004) 621-625
46. Wolfberg A.J., Lee-Parritz A., Peller A.J., and Lieberman E.S. Association of rheumatologic disease with preeclampsia. Obstet Gynecol 103 (2004) 1190-1193
47. Skomvoll J.F., Baste V., Irgens L.M., and Ostensen M. The recurrence risk of adverse outcome in second pregnancy in women with rheumatic disease. Obstet Gynecol 100 (2002) 1196-1202
48. Goodlin R.C., Anderson J.C., and Skiles T.L. Pruritus and hyperplacentosis. Obstet Gynecol 66 (1985) 36S-38S
49. Sundstrom J.B., Fett J.D., Caraway R.D., and Ansari A.A. Is peripartum cardiomyopathy and organ-specific autoimmune disease?. Autoimmune Rev 1 (2002) 73-77
50. Elkayam U., Akhter M.W., Singh H., Khan S., Bitar F., Hameed A., et al. Pregnancy-associated cardiomyopathy. Clinical characteristics and a comparison between early and late presentation. Circulation 111 (2005) 2050-2055
51. Gleicher N. Reproductive failure prior to the onset of clinical autoimmune disease. Rheumatology 38 (1999) 485-487
52. Gleicher N., El Roeiy A., Confino E., and Friberg J. Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 160 (1989) 1376-1385
53. Gleicher N. Autoantibodies and pregnancy loss. Lancet 343 (1994) 747-748
54. Gleicher N. Modern obstetrical and infertility care may increase the prevalence of disease: an evolutionary concept. Fertil Steril 79 (2003) 249-252
55. Fairweather D., and Rose N.R. Type 1 diabetes: virus infection or autoimmune disease?. Nat Immun 3 (2002) 338-340